# Paclitaxel

NDC: 75007-041
Generic name: Paclitaxel (aibumin-bound)
Labeler / Manufacturer: Ningbo Shuangcheng Pharmaceutical Co., Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20250515

FDA application: ANDA216355

## Active ingredients

- PACLITAXEL: 100 mg/100mg

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"75007-041"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=75007-041
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4df3fda6-0b29-420e-ab91-81441ce914ed